In this Section |
271398 Patient-reported Barriers to Statin Therapy AdherenceTuesday, October 30, 2012
: 2:45 PM - 3:00 PM
Background: Non-adherence to statin therapy is associated with poor cardiovascular outcomes; however, there is limited information on the barriers that limit patient adherence. Methods: We conducted telephone interviews with a stratified random sample of adults receiving statin therapy within an integrated delivery system (N=730, 81.5% response rate). We oversampled patients with low adherence based on the proportion of days covered using automated pharmacy data. We assessed self-reported adherence, and 15 concerns and potential barriers to adherence (e.g., costs, convenience, side-effects, and lifestyle concerns). We used logistic regression to examine predictors of non-adherence and weighted all analyses for sampling proportions. Results: Overall, 17.7% reported splitting or skipping statin pills without their doctor's advice, 4.8% stopped refilling their statin prescription, and 3.1% did not fill a new statin prescription in the previous 12 months; 21.8% reported any of these behaviors. Patients reported a range of concerns, the most common were preferring to lower cholesterol with lifestyle changes such as diet or exercise (65.7%), generally disliking taking medications (58.6%), and concerns about liver or kidney problems associated with statin use (30.9%). In multivariate analyses, younger subjects, and those unsure of the benefits of statins, reporting logistical problems, and having risk/side-effect concerns were more likely to report poor adherence (all p<0.05); having lifestyle concerns (e.g., preferring diet/exercise, disliking medications in general) was not significantly associated with poor adherence. Conclusions: Patients face a range of barriers to statin adherence. Better understanding these factors is critical for designing effective interventions to improve adherence.
Learning Areas:
Chronic disease management and preventionLearning Objectives: Keywords: Treatment Adherence, Cholesterol
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I have been principal or co-investigator on multiple federally funded grants focusing on drug treatment adherence. Among my scientific interests is the identification of patient modifiable barriers to adherence to inform approaches and interventions to improve adherence. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
Back to: 4306.0: Other Topics in Epidemiology
|